NO894296L - Fremgangsmaate for behandling av leddgikt og betennelsessykdommer. - Google Patents
Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.Info
- Publication number
- NO894296L NO894296L NO89894296A NO894296A NO894296L NO 894296 L NO894296 L NO 894296L NO 89894296 A NO89894296 A NO 89894296A NO 894296 A NO894296 A NO 894296A NO 894296 L NO894296 L NO 894296L
- Authority
- NO
- Norway
- Prior art keywords
- arthy
- procedure
- treatment
- inflammatory diseases
- inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/293,196 US4863928A (en) | 1989-01-04 | 1989-01-04 | Method of treatment for arthritic and inflammatory diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
NO894296D0 NO894296D0 (no) | 1989-10-27 |
NO894296L true NO894296L (no) | 1990-07-05 |
Family
ID=23128099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO89894296A NO894296L (no) | 1989-01-04 | 1989-10-27 | Fremgangsmaate for behandling av leddgikt og betennelsessykdommer. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4863928A (no) |
EP (1) | EP0377272A3 (no) |
JP (1) | JPH02184628A (no) |
AU (1) | AU619937B2 (no) |
CA (1) | CA1333772C (no) |
DK (1) | DK674389A (no) |
IL (1) | IL91302A (no) |
NO (1) | NO894296L (no) |
ZA (1) | ZA898013B (no) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5013739A (en) * | 1986-10-07 | 1991-05-07 | Bernard Bihari | Method of treating chronic fatigue syndrome using an opiate receptor antagonist |
US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
US5086058A (en) * | 1990-06-04 | 1992-02-04 | Alko Ltd. | Method for treating alcoholism with nalmefene |
US6096756A (en) * | 1992-09-21 | 2000-08-01 | Albert Einstein College Of Medicine Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
US5376662A (en) * | 1993-12-08 | 1994-12-27 | Ockert; David M. | Method of attenuating nerve injury induced pain |
SE9304236D0 (sv) * | 1993-12-22 | 1993-12-22 | Astra Ab | New use |
US5878750A (en) * | 1996-11-14 | 1999-03-09 | Clemens; Anton H. | Method of treating the syndrome of coronary heart disease risk factors in humans |
US6203813B1 (en) | 1997-01-13 | 2001-03-20 | Lance L. Gooberman | Pharmaceutical delivery device and method of preparation therefor |
AU1807401A (en) * | 1999-11-30 | 2001-06-12 | Corixa Corporation | Compositions and methods for therapy and diagnosis of breast cancer |
US20040024004A1 (en) * | 2001-05-04 | 2004-02-05 | Sherman Barry M. | Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists |
US6528520B2 (en) | 2000-08-15 | 2003-03-04 | Cpd, Llc | Method of treating the syndrome of coronary heart disease risk factors in humans |
US6262062B1 (en) | 2000-08-15 | 2001-07-17 | Cpd, Llc | Method of treating the syndrome of coronary heart disease risk factors in humans |
US6846831B2 (en) | 2000-08-15 | 2005-01-25 | Cpd, Llc | Method of treating the syndrome of lipodystrophy |
CN1273075C (zh) * | 2001-07-13 | 2006-09-06 | 爱科来株式会社 | 分析用具、具备分析用具的浓度测定装置用的穿刺元件一体化安装体及体液采取用具 |
US7501433B2 (en) * | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US7923454B2 (en) | 2002-05-17 | 2011-04-12 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
MXPA04011327A (es) * | 2002-05-17 | 2005-08-15 | Jenken Biosciences Inc | Opioides y compuestos similares a opioides y usos de los mismos. |
US6972291B2 (en) * | 2002-07-02 | 2005-12-06 | Bernstein Richard K | Method for reducing food intake |
CN104383542B (zh) | 2003-04-08 | 2017-09-26 | 普罗热尼奇制药公司 | 包含甲基纳曲酮的药物配方 |
CA2522471A1 (en) * | 2003-04-14 | 2004-10-28 | Pain Therapeutics, Inc. | Methods for the treatment of pain comprising opioid antagonists |
US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US20050245557A1 (en) * | 2003-10-15 | 2005-11-03 | Pain Therapeutics, Inc. | Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain |
US20060009478A1 (en) * | 2003-10-15 | 2006-01-12 | Nadav Friedmann | Methods for the treatment of back pain |
EP1750711B1 (en) | 2004-05-12 | 2016-10-26 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Treatment of inflammatory conditions with morphinans |
US8518962B2 (en) | 2005-03-07 | 2013-08-27 | The University Of Chicago | Use of opioid antagonists |
US8524731B2 (en) | 2005-03-07 | 2013-09-03 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
MX2007010833A (es) | 2005-03-07 | 2009-02-17 | Univ Chicago | Uso de antagonistas opioides para atenuar proliferacion y migracion de células endoteliales. |
US9662325B2 (en) | 2005-03-07 | 2017-05-30 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
AR057325A1 (es) | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos |
AR057035A1 (es) | 2005-05-25 | 2007-11-14 | Progenics Pharm Inc | SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS |
US20080194611A1 (en) * | 2005-06-03 | 2008-08-14 | Alverdy John C | Modulation of Cell Barrier Dysfunction |
EP1901742A2 (en) * | 2005-06-03 | 2008-03-26 | The University of Chicago | Modulation of cell barrier dysfunction |
MX2008013441A (es) * | 2006-04-19 | 2009-02-11 | Jill P Smith | Tratamiento de enfermedades inflamatorias y ulcerativas del intestino con antagonistas opioides. |
US20070259939A1 (en) * | 2006-05-04 | 2007-11-08 | Accelerated Technologies | Using naltrexone as a multi-purpose health supplement to improve the human condition and preventing multiple diseases and infirmities by stimulating immune system vitality and robustness |
SI2139890T1 (sl) | 2007-03-29 | 2014-12-31 | Wyeth Llc | Antagonisti perifernih opioidnih receptorjev in njih uporaba |
MX351611B (es) | 2007-03-29 | 2017-10-20 | Wyeth Llc | Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas. |
PA8774201A1 (es) | 2007-03-29 | 2009-06-23 | Progenics Pharm Inc | Antagonista del receptor |
EP2730578A1 (en) | 2008-02-06 | 2014-05-14 | Progenics Pharmaceuticals, Inc. | Preparation and use of (r),(r)-2,2'-bis-methylnal trexone |
EP2278966B1 (en) | 2008-03-21 | 2019-10-09 | The University of Chicago | Treatment with opioid antagonists and mtor inhibitors |
CA2676881C (en) | 2008-09-30 | 2017-04-25 | Wyeth | Peripheral opioid receptor antagonists and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE51145B1 (en) * | 1980-03-07 | 1986-10-15 | Efamol Ltd | Pharmaceutical and dietary compositions |
HU196376B (en) * | 1985-05-23 | 1988-11-28 | Sandoz Ag | Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds |
US4760069A (en) * | 1985-09-23 | 1988-07-26 | Nova Pharmaceutical Corporation | Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists |
US4673679A (en) * | 1986-05-14 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration |
FR2609632B1 (fr) * | 1987-01-21 | 1991-03-29 | Shelly Marc | Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage |
US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
-
1989
- 1989-01-04 US US07/293,196 patent/US4863928A/en not_active Expired - Fee Related
- 1989-08-14 IL IL9130289A patent/IL91302A/en not_active IP Right Cessation
- 1989-08-21 JP JP1215893A patent/JPH02184628A/ja active Pending
- 1989-08-22 CA CA000608936A patent/CA1333772C/en not_active Expired - Fee Related
- 1989-09-18 EP EP19890309448 patent/EP0377272A3/en not_active Ceased
- 1989-10-23 ZA ZA898013A patent/ZA898013B/xx unknown
- 1989-10-27 NO NO89894296A patent/NO894296L/no unknown
- 1989-12-29 DK DK674389A patent/DK674389A/da not_active Application Discontinuation
-
1990
- 1990-01-03 AU AU47630/90A patent/AU619937B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU619937B2 (en) | 1992-02-06 |
IL91302A0 (en) | 1990-03-19 |
NO894296D0 (no) | 1989-10-27 |
US4863928A (en) | 1989-09-05 |
IL91302A (en) | 1994-05-30 |
DK674389A (da) | 1990-07-05 |
EP0377272A3 (en) | 1991-09-25 |
ZA898013B (en) | 1990-08-29 |
JPH02184628A (ja) | 1990-07-19 |
EP0377272A2 (en) | 1990-07-11 |
DK674389D0 (da) | 1989-12-29 |
CA1333772C (en) | 1995-01-03 |
AU4763090A (en) | 1990-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO894296L (no) | Fremgangsmaate for behandling av leddgikt og betennelsessykdommer. | |
NO911952L (no) | Behandling av tilstander og sykdommer samt midler derfor. | |
NO883540D0 (no) | Fremgangsmaate og anlegg for behandling av slam. | |
NO893240L (no) | Anvendelse av alfa-aminoborsyrederivater til profylaktisk og behandling av virussykdommer. | |
NO890045L (no) | Baatskrog og fremgangsmaate for fremstilling og belegging derav. | |
NO953254D0 (no) | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter | |
NO882940D0 (no) | Fremgangsmaate for fremstilling av castanosperminestere og glycosider. | |
NO922531D0 (no) | Middel for forhindring av og behandling av fiskesykdommer | |
NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
NO883220D0 (no) | Innretning og preparat for behandling av gommene. | |
NO880292D0 (no) | Fremgangsmaate for behandling av humle. | |
NO881713D0 (no) | Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere. | |
NO920983L (no) | Fremgangsmaate for behandling av nevrodegenerative tilstander | |
NO891630D0 (no) | Fremgangsmaate og anordning for fremstilling av diafragmer. | |
NO892257L (no) | Fremgangsmaate og anordning for oppfoering av gulvkonstruksjoner. | |
NO882336L (no) | Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener. | |
NO905543L (no) | Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer. | |
NO884635D0 (no) | Fremgangsmaate for behandling av most. | |
NO823424L (no) | Fremgangsmaate til fremstilling og behandling av ferrokrom | |
NO874487D0 (no) | Framgangsmaate for tilvirkning av poelser og liknende produkter. | |
DK670588A (da) | Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet | |
NO912279D0 (no) | Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter. | |
FI890595A (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara tiadiazoler. | |
NO902968L (no) | Fremgangsmaate for behandling av boreslam. | |
NO905643L (no) | Fremgangsmaate for behandling av manganslam. |